Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from ALB

Albemarle Stock: Is Wall Street Bullish or Bearish?

Specialty chemical giant Albemarle has underperformed the broader market over the past year, and analysts remain cautious about the stock’s prospects.

Barchart

3 Signals Pointing to a Turnaround for Albemarle

Albemarle is strengthening its balance sheet with an asset sale as a wave of analyst upgrades suggests a potential recovery for the lithium leader.

MarketBeat

Stock Of The Day: Trading Opportunities In Albemarle?

Albemarle Corporation (NYSE:ALB) is trading lower on Monday. The shares were up on Friday but, at last check on Monday, were down over 6.3%. This move followed positive comments and a new ‘buy' recommendation from a brokerage firm.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Albemarle Nets $660 Million From Asset Sales, Keeps Foot In Ketjen's Future

Albemarle Corporation (NYSE:ALB), a supplier of materials used in mobility, energy, connectivity, and health applications, has entered into a definitive agreement to sell a controlling interest in Ketjen Corporation’s refining catalyst solutions business to KPS Capital Partners, LP.

Benzinga

This Albemarle Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

Benzinga

Albemarle Earnings Preview: What to Expect

Albemarle is prepared to release its third-quarter results next month, with analysts predicting a significant double-digit earnings rise.

Barchart

Stock Of The Day: Reversal Time For Albemarle?

Trading in Albemarle Corporation (NYSE:ALB) is quiet Friday. The stock has stalled at a resistance level.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

5 EV Battery and Lithium Stocks Charging the Future

The EV battery market is projected to exceed $250 billion by 2035, presenting investors with opportunities in both lithium giants and high-risk innovators.

MarketBeat

Lithium Americas Rally Lifts Other Rare Earth Stocks

Lithium Americas (LAC) surged 90% after a U.S. government stake fueled rare earth momentum, putting Albemarle (ALB) and Uranium Energy (UEC) on watch.

MarketBeat

Abermarle Shares Are Trading Higher Wednesday: What's Going On?

Shares of Albemarle Corporation (NYSE:ALB) are trading higher Wednesday alongside several other lithium stocks after Lithium Americas Corp. (NYSE:LAC) surged on reports that the Trump administration is seeking an equity stake in the company.

Benzinga

Is Albemarle Stock Underperforming the Nasdaq?

Albemarle has underperformed the Nasdaq over the past year, and analysts are cautious about the stock’s prospects.

Barchart

Albemarle Stock: Analyst Estimates & Ratings

As Albemarle has underperformed relative to the SPX over the past year, Wall Street analysts maintain a cautious outlook about the stock’s prospects.

Barchart

While Albemarle's Stock Jump Captures The Spotlight, A Critical Chinese Supply Disruption Could Test The EV Battery Market

Albemarle Corp (NYSE:ALB), a leading global producer of lithium for electric vehicle batteries, shares are surging Monday afternoon following news that could significantly tighten the global lithium supply. Here’s what investors need to know.

Benzinga

Albemarle Stock Rises On Q2 Earnings Beat, Strong Guidance

Albemarle Corp (NYSE:ALB) reported financial results for the second quarter after the market close on Wednesday. Here’s a rundown of the report.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

This Albemarle Analyst Turns Bearish; Here Are Top 5 Downgrades For Tuesday

Barchart

What You Need to Know Ahead of Albemarle's Earnings Release

Albemarle will release its second-quarter earnings later this month, and analysts anticipate a significant loss dip.

Barchart

Is Albemarle Stock Underperforming the S&P 500?

While Albemarle has considerably underperformed the S&P 500 recently, analysts remain moderately optimistic about the stock’s prospects.

MarketBeat

As Gold Surges, Albemarle Stock May Be the Next to Pop

Albemarle stock could be set to rally by double-digit percentages on this metals rally, and it's current discount means asymmetric returns for investors.

Get all your
news in one place.

100’s of premium titles.
One news app.

Kiplinger

AI vs the Stock Market: How Did Tech Stocks, Palantir and Albemarle Perform in May?

AI is a new tool to help investors analyze data, but can it beat the stock market? Here's how a chatbot's stock picks fared in May.

MarketBeat

Why Albemarle Stock Could Have a Major Run This Year

Albemarle stock has fallen to a discount that attracted institutional buyers to come in and buy up shares of this high upsdie name.

Barchart

Do Wall Street Analysts Like Albemarle Stock?

Despite Albemarle's significant underperformance relative to the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.

Barchart

What to Expect From Albemarle's Next Quarterly Earnings Report

Albemarle is prepared to release its first-quarter results next week, with analysts predicting a significant triple-digit earnings drop.

MarketBeat

3 High Short Interest Stocks Set to Pop After Tariff Fears Fade

Celsius, CAVA, and Albemarle may rally soon. Learn why high short interest and tariff clarity could trigger major short squeezes in these top stocks.

MarketBeat

Tariff-Proof Stocks: 3 Big Bargains With Huge Upside Potential

Discover 3 undervalued stocks that may benefit from tariffs and offer major upside in a volatile market: Albemarle, Celsius, and Cleveland-Cliffs.

Barchart

How Is Albemarle's Stock Performance Compared to Other Basic Material Stocks?

Despite Albemarle's underperformance relative to its industry peers over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

1 2 3 4

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.